1. Home
  2. CYTK vs EAT Comparison

CYTK vs EAT Comparison

Compare CYTK & EAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$70.05

Market Cap

8.3B

Sector

Health Care

ML Signal

HOLD

Logo Brinker International Inc.

EAT

Brinker International Inc.

HOLD

Current Price

$141.00

Market Cap

7.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
CYTK
EAT
Founded
1997
1975
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
8.3B
7.2B
IPO Year
2004
1994

Fundamental Metrics

Financial Performance
Metric
CYTK
EAT
Price
$70.05
$141.00
Analyst Decision
Strong Buy
Buy
Analyst Count
17
18
Target Price
$85.59
$184.41
AVG Volume (30 Days)
1.5M
1.3M
Earning Date
01-01-0001
04-27-2026
Dividend Yield
N/A
N/A
EPS Growth
3.49
144.71
EPS
N/A
5.03
Revenue
$13,368,000.00
$5,384,200,000.00
Revenue This Year
$341.94
$8.99
Revenue Next Year
$48.30
$5.47
P/E Ratio
N/A
$27.93
Revenue Growth
N/A
21.95
52 Week Low
$29.31
$100.30
52 Week High
$70.98
$187.12

Technical Indicators

Market Signals
Indicator
CYTK
EAT
Relative Strength Index (RSI) 56.80 34.18
Support Level $59.23 $139.52
Resistance Level $67.75 $169.95
Average True Range (ATR) 2.38 7.22
MACD 0.33 -3.12
Stochastic Oscillator 79.93 12.96

Price Performance

Historical Comparison
CYTK
EAT

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About EAT Brinker International Inc.

Brinker International Inc operates casual dining restaurants under the brand's Chili Grill and Bar (Chili's) and Maggiano's Little Italy (Maggiano's). Chili's falls in the Bar and Grill category of casual dining. Its menu features Fresh Mex and Fresh Tex favorites including signature items such as slow-smoked baby back ribs, craft burgers, fajitas, and bottomless chips and salsa paired with tableside guacamole. Maggiano's is an Italian restaurant brand with a full lunch and dinner menu offering chef-prepared, such as appetizers, chicken, seafood, veal and prime steaks, and desserts. The company generates maximum revenue from Chili's segment.

Share on Social Networks: